Searchable abstracts of presentations at key conferences in endocrinology

ea0011p409 | Diabetes, metabolism and cardiovascular | ECE2006

Lipoprotein Lp(a) in patients with systemic lupus erythematosus

Athanassiou P , Kostoglou-Athanassiou I , Kordalis A , Kalogirou Th , Galanaki Ch , Bastakis E , Kaldrymidis Ph

Systemic lupus erythematosus (SLE) is a multifactorial multisystem autoimmune disorder. Although the survival of SLE patients has been improved with the administration of immunomodulatory therapy, patients seem to suffer from complications of the disease such as atherosclerosis. Lipoprotein Lp(a) is a known risk factor for the development of atherosclerosis.The aim was to evaluate lipoprotein Lp(a) and its relationship with disease activity in patients w...

ea0011p412 | Diabetes, metabolism and cardiovascular | ECE2006

Lipoprotein Lp(a) in patients with rheumatoid arthritis

Athanassiou P , Kostoglou-Athanassiou I , Kordalis A , Kalogirou Th , Galanaki Ch , Bastakis E , Kaldrymidis Ph

Epidemiological studies show increased mortality in patients with rheumatoid arthritis (RA). One of the causes of death in RA patients is cardiovascular disease. Lipoprotein Lp(a) appears to be an independent risk factor for the development of cardiovascular diseases. The aim of the study was to evaluate serum lipid and lipoprotein Lp(a) levels in patients with RA.Patients with RA, n=50, aged 24–65 years and healthy controls, n=50 were...

ea0014p89 | (1) | ECE2007

Lipoprotein Lp(a) in patients with systemic lupus erythematosus. Relationship with disease activity and anticardiolipin antibodies

Athanassiou Panagiotis , Kostoglou-Athanassiou Ifigenia , Papadopoulou Despina , Galanaki Chrysoula , Kalogirou Thomais , Kordalis Athanasios , Antoniadis Christodoulos , Kaldrymidis Philippos

Systemic lupus erythematosus (SLE) is a multisystem multifactorial autoimmune disorder. The survival of SLE patients has been improved by the administration of immunomodulatory therapy. Patients, however, are affected by late onset complications of the disease such as atherosclerosis. Lipoprotein Lp(a) is a known risk factor for the development of atherosclerosis.The aim was to study Lp(a) levels and their relationship with disease activity in SLE patien...

ea0014p90 | (1) | ECE2007

Lipoprotein Lp(a) in patients with rheumatoid arthritis and its relationship with disease activity

Athanassiou Panagiotis , Kostoglou-Athanassiou Ifigenia , Papadopoulou Despina , Galanaki Chrysoula , Kalogirou Thomais , Kordalis Athanasios , Antoniadis Christodoulos , Kaldrymidis Philippos

Epidemiological studies indicate that rheumatoid arthritis (RA) patients have increased mortality. Cardiovascular disease seems to be one of the major causes of death in patients with RA. Lipoprotein disorders are observed in patients with systemic autoimmune disorders as well as in patients with RA. Lipoprotein Lp(a) is an independent risk factor for the development of cardiovascular disease.The aim of the study was estimate lipoprotein Lp(a) levels and...